Skip to main content
Clinical Trials/NCT03253666
NCT03253666
Completed
Not Applicable

Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)

Harvard School of Public Health (HSPH)0 sites173,229 target enrollmentJanuary 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Skin Cancer
Sponsor
Harvard School of Public Health (HSPH)
Enrollment
173229
Primary Endpoint
Multiple skin diseases
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

To determine the relationships of dietary factors with the subsequent risk of dermatological diseases (such as skin cancers and inflammatory or autoimmune dermatoses) in a cohort of female registered nurses and male health professionals.

Detailed Description

The study population consisted of two ongoing cohorts: the Nurses' Health Study (NHS) and Health Professionals Follow-Up Study (HPFS). The NHS began in 1976 when 121,700 female nurses aged 33-55 years and residing in the United States responded to a baseline questionnaire. The HPFS began in 1986 when 51,529 male health professionals aged 40-75 years and residing in the United States completed a similar baseline questionnaire. Study investigators sent follow-up questionnaires biennially to participants to update information on past medical history as well as lifestyle factors. Follow up was started in 1984 for the NHS and 1986 for the HPFS when diet was measured with an expanded food frequency questionnaire (FFQ). Participants in the NHS responded to an \~130 item semi-quantitative FFQ in 1984, 1986, and then every four years thereafter, while those in the HPFS responded to a similar FFQ in 1986 and then every four years thereafter. The FFQ collected information on average intake of each food item over the past year. It also specified a common serving size for each item. Participants could select from one of nine intake frequency choices, ranging from less than once per month to six or more times per day. Participants also provided information on current use and dose of multivitamins and use of other vitamin supplements. For both cohorts, investigators repeatedly collected and updated information on several anthropometric and lifestyle factors such as weight, smoking status, alcohol use, coffee intake, and physical activity level. Information was also collected on several major risk factors for skin disease such as family history of melanoma, number of arm moles, natural hair color, sunburn susceptibility as a child or adolescent, number of lifetime blistering sunburns, type of tan after repeated sun exposure as a child or adolescent, and cumulative ultraviolet flux since baseline. Study subjects reported new diagnoses biennially. After obtaining permission from participants, their medical and pathological records were acquired. Study physicians blinded to questionnaire information reviewed these records to confirm diagnoses The study was approved by the institutional review boards of both Brigham and Women's Hospital and Harvard T.H Chan School of Public Health.

Registry
clinicaltrials.gov
Start Date
January 2017
End Date
May 2018
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Harvard School of Public Health (HSPH)
Responsible Party
Principal Investigator
Principal Investigator

Ashar Dhana

Research Associate

Harvard School of Public Health (HSPH)

Eligibility Criteria

Inclusion Criteria

  • Participants of these two cohorts

Exclusion Criteria

  • Participants with missing data on dietary intake at baseline
  • Participants with a prior history of cancer (except non-melanoma skin cancer)
  • For skin cancer, non-white participants because of low risk of skin cancer (such as melanoma) and small numbers.
  • For melanoma, participants with in-situ melanomas, which comprise tumours restricted to the epidermis of the skin.

Outcomes

Primary Outcomes

Multiple skin diseases

Time Frame: Skin disease/cancer [ NHS: Time Frame: 1984 - 2010 ] [ HPFS: Time Frame: 1986 - 2010 ]. Person time contribution from date of return of questionnaire to date of first report of skin disease/death/end of follow-up (whichever came first)

Includes skin cancer, psoriasis, and other inflammatory and autoimmune skin diseases.

Similar Trials